Is MOTS-c Legal in Washington State?

HealthRX.com

Washington rules are not covered here; federal status is clear

Print or save as PDF

Key numbers

  • 5 mgNominated MOTS-c product strength: one of two 5 mg and 10 mg subcutaneous injections; no approved dose existsSource: fda.gov, as cited Nov 7, 2026
  • 10 mgNominated MOTS-c product strength: the higher of two subcutaneous injection doses, 5 mg and 10 mg, with no human dosing studySource: fda.gov, as cited Nov 7, 2026
  • 970 daysMedian lifespan of mice on a late-life MOTS-c schedule, up from 912 days; animal data only, not human evidenceSource: fda.gov, as cited Nov 7, 2026

See the public record for MOTS-c

  • FDA approval / None. Not an approved drug, not a component of one [1]
  • FDA compounding lists / On neither list, and in none of the three interim categories [2][3][5]
  • Advisory committee / Voted to recommend adding it, 23 July 2026; advice only [6][4]
  • HHS draft policy / Names MOTS-c among six peptides; draft [4][7]
  • Human studies / None in which MOTS-c was given to a person [1]
  • Anti-doping / Prohibited at all times by WADA under S4.4.1 [8]

What MOTS-c is

MOTS-c is a 16-amino-acid peptide, molecular weight about 2174.6 g/mol, encoded in mitochondrial DNA and first reported in 2015 by Lee et al. in Cell Metabolism [1][9]. It is sold on websites, alone and in combinations such as a clinic's IV cocktail, for metabolism, weight loss, glucose control, performance and anti-aging [1].

Federal status

MOTS-c is not an FDA-approved drug and is not a component of one. FDA's July 2026 review found no USP or National Formulary monograph, no listing in the European or Japanese pharmacopeias and no EMA-authorised product [1].

For compounding, FDA says a state-licensed pharmacy or physician may use a bulk substance that has a USP or National Formulary monograph, is a component of an FDA-approved product, or appears on FDA's bulks list [5]. MOTS-c meets none of those: it appears on neither FDA's list for state-licensed pharmacies (updated 14 May 2026) nor its list for outsourcing facilities (updated 21 March 2025), and it falls outside all three interim categories [2][3][5]. FDA's page on bulk substances that may present significant safety risks lists it in the nominated-but-withdrawn table, which holds substances previously in category 2 whose nominators withdrew them. There FDA states it had not identified human exposure data by any route and that injectable peptides may pose immunogenicity risk from aggregation and impurities. Removal from category 2 was not a finding that MOTS-c is safe [10].

Questions worth asking

Choose the questions you want to keep

The committee vote and the HHS draft policy

On 23 July 2026 the Pharmacy Compounding Advisory Committee voted in favor of adding MOTS-c to the bulks list, against FDA staff's recommendation that neither the free base nor the acetate be added. The vote is advice only, and MOTS-c is not on the list; adding it takes formal rulemaking [6][4].

HHS has filed a draft enforcement-discretion policy naming MOTS-c among six peptides, covering the acetate form and subcutaneous or intramuscular injection [4][7]. HHS says it 'does not intend to take enforcement action' against a state-licensed pharmacy, federal facility or licensed physician compounding it if conditions are met, such as a single active ingredient, a patient-specific prescription, an FDA-registered manufacturer holding a certificate of analysis, and the label 'This is a compounded drug product. Not for resale.' [4][7]. The notice says it 'does not establish any rights for any person and is not binding on HHS or the public', and HHS may revisit it, for example if a safety signal or product quality issue arises [4]. Compounded drugs are not FDA-approved: FDA does not review their safety, effectiveness or quality before marketing [4].

What people on Reddit report

Reddit posts reacting to the new HHS compounding policy. Accounts are split between people who expect more access and people who fear higher prices and fewer sources. They concern federal policy, not Washington law.

RustyHour1975 · Supplements

I don't see this as expanded access. I see it as the beginning of fewer choices, higher prices, and more corporate control over products people are already using.

A poster who already buys peptides says the policy will reduce choice and raise prices rather than widen access.

Read the source discussion

Fun_Lemon_9873 · Supplements

Peptides are pretty easy to get prescribed. There are online HRT clinics that prescribe certain peptides like they're hot cakes.

A commenter reports that prescribed peptides are easy to get through online clinics, at a higher cost than gray-market sources.

Read the source discussion

kirkt · Supplements

I'm no fan of the FDA by any means, but having sources that can be held to account is a good option.

A commenter prefers accountable sources over gray-market products, even while criticizing the FDA.

Read the source discussion

Athletes

WADA's Prohibited List names MOTS-c in S4.4.1 among activators of AMP-activated protein kinase, prohibited at all times in and out of competition; S4.4 substances are non-Specified Substances, and it appears on the 2026 and 2027 Lists [8][11].

Is there human evidence?

FDA found no clinical study in which MOTS-c was given to a human; the 12 papers the nominator cited were not clinical studies [1]. In mice, injected MOTS-c reduced weight gain on a high-fat diet, and a late-life schedule lengthened median lifespan from 912 to 970 days [1]. Human work has measured the body's own peptide: exercise induces MOTS-c expression in skeletal muscle and in circulation [12], and in one trial of 30 healthy adults plasma MOTS-c showed only a trend to rise after endurance exercise [13]. There is no approved dose and no human dosing study; the nominated products were 5 mg and 10 mg subcutaneous injections [1].

Is MOTS-c legal in Washington State?
This page does not establish Washington's own rules on the peptide, so the state question stays open. Federally, MOTS-c is not an FDA-approved drug and appears on neither of FDA's compounding bulk-substance lists [1][2][3]. HHS's October 2026 peptide policy is a draft that establishes no rights for any person [4].
Can a pharmacy compound MOTS-c?
FDA says a state-licensed pharmacy may compound with a bulk substance that has a USP or National Formulary monograph, is a component of an approved product, or is on FDA's bulks list [5]. MOTS-c meets none of those, and FDA staff recommended against adding it [1]. The HHS draft policy would apply only if its conditions were met, including the acetate form, a patient-specific prescription and an FDA-registered manufacturer holding a certificate of analysis [4][7].
Is MOTS-c FDA approved?
No. MOTS-c is not an FDA-approved drug and is not a component of one; FDA found no pharmacopoeial monograph and no product authorised by the European Medicines Agency [1].
Is MOTS-c banned for athletes?
Yes. WADA names MOTS-c in S4.4.1 as an AMPK activator, prohibited at all times in and out of competition, and it appears on the 2026 and 2027 Lists [8][11].
Show all 14 referencesHide references
  1. U.S. Food and Drug Administration.
  2. U.S. Food and Drug Administration.
  3. U.S. Food and Drug Administration.
  4. Official web page.
  5. Bulk Drug Substances Used in Compounding of the FD&C Act | FDA.
  6. U.S. Food and Drug Administration.
  7. Official web page.
  8. World Anti-Doping Agency.
  9. Lee C, Zeng J, Drew BG, Sallam T, Martin-Montalvo A, Wan J, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-54.
  10. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
  11. World Anti-Doping Agency.
  12. Reynolds JC, Lai RW, Woodhead JST, Joly JH, Mitchell CJ, Cameron-Smith D, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12(1):470.
  13. von Walden F, Fernandez-Gonzalo R, Norrbom J, Emanuelsson EB, Figueiredo VC, Gidlund EK, et al. Acute endurance exercise stimulates circulating levels of mitochondrial-derived peptides in humans. J Appl Physiol (1985). 2021;131(3):1035-1042.
  14. Reddit participants. RFK Jr. Opens the Door to Six Previously Restricted Peptides — Major Shift in FDA Policy (r/Supplements). Accessed 2026-11-11.
Evidence overview for Is MOTS-c Legal in Washington State?